CNS Pharmaceuticals Inc (CNSP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.22M
Last updated: Nov 17, 2026 at 10:56 AM ET
CNS Pharmaceuticals Inc (CNSP) Earnings: Report Dates and Results
CNS Pharmaceuticals (CNSP) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, CNS Pharmaceuticals reported EPS of -$0.38, below the -$0.24 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CNSP has an expected report date of Mar 29, 2027.
Earnings History
Of the 24 quarters below that had an estimate, CNSP beat 10 and missed 14. The widest gap in the table came in the quarter ended Dec 31, 2019, when EPS landed 466.67% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.38 | -$0.24 | -$0.24 - -$0.24 | -58.33% | Miss | N/A | 1 | 0 up, 0 down | Aug 12, 2026 |
| Mar 31, 2026 | -$7.30 | -$5.37 | -$5.37 - -$5.37 | -35.94% | Miss | N/A | 1 | 0 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$10.15 | -$5.09 | -$5.09 - -$5.09 | -99.41% | Miss | N/A | 1 | 0 up, 0 down | Mar 31, 2026 |
| Sep 30, 2025 | -$5.76 | -$6.63 | -$6.63 - -$6.63 | +13.12% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$6.42 | -$9.60 | N/A | +33.13% | Beat | N/A | N/A | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$1.58 | -$2.00 | N/A | +21.00% | Beat | N/A | N/A | 0 up, 0 down | May 15, 2025 |
| Dec 31, 2024 | -$37.33 | -$7.33 | N/A | -409.28% | Miss | N/A | 1 | 0 up, 0 down | Mar 31, 2025 |
| Sep 30, 2024 | -$150.00 | -$60.00 | N/A | -150.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$6.72 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 14, 2024 |
| Mar 31, 2024 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Apr 1, 2024 |
| Dec 31, 2023 | -$28,622.96 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Mar 14, 2024 |
| Sep 30, 2023 | -$32,400.01 | -$51,900.02 | N/A | +37.57% | Beat | N/A | N/A | N/A | Nov 14, 2023 |
| Jun 30, 2023 | -$31,200.01 | -$84,600.03 | N/A | +63.12% | Beat | N/A | N/A | N/A | Aug 14, 2023 |
| Mar 31, 2023 | -$2.59 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$3.82 | -$2.40 | N/A | -59.21% | Miss | N/A | N/A | 0 up, 0 down | Mar 31, 2023 |
| Sep 30, 2022 | -$81,000.11 | -$90,000.13 | N/A | +10.00% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$81,000.11 | -$72,000.10 | N/A | -12.50% | Miss | N/A | 1 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$63,000.09 | -$126,000.18 | N/A | +50.00% | Beat | N/A | 1 | 0 up, 0 down | May 16, 2022 |
| Dec 31, 2021 | -$3.00 | -$4.80 | -$6.31 - -$3.30 | +37.50% | Beat | N/A | 2 | 0 up, 0 down | Mar 3, 2022 |
| Sep 30, 2021 | -$126,000.18 | -$132,000.18 | -$189,264.90 - -$99,138.75 | +4.55% | Beat | N/A | 4 | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$135,000.19 | -$117,000.16 | -$144,201.82 - -$90,126.14 | -15.38% | Miss | N/A | 2 | N/A | Aug 13, 2021 |
| Mar 31, 2021 | -$135,000.19 | -$108,000.15 | N/A | -25.00% | Miss | N/A | 2 | N/A | May 14, 2021 |
| Dec 31, 2020 | -$162,000.23 | -$105,750.15 | -$117,163.98 - -$81,113.53 | -53.19% | Miss | N/A | 4 | N/A | Feb 12, 2021 |
| Sep 30, 2020 | -$108,000.15 | -$112,500.16 | -$117,163.98 - -$108,151.37 | +4.00% | Beat | N/A | 2 | N/A | Nov 12, 2020 |
| Jun 30, 2020 | -$135,000.19 | -$72,000.10 | N/A | -87.50% | Miss | N/A | N/A | N/A | Aug 10, 2020 |
| Mar 31, 2020 | -$108,000.15 | -$90,000.13 | N/A | -20.00% | Miss | N/A | 1 | N/A | May 15, 2020 |
| Dec 31, 2019 | -$5.10 | -$0.90 | -$0.90 - -$0.90 | -466.67% | Miss | N/A | 1 | N/A | Mar 12, 2020 |
| Sep 30, 2019 | -$45,000.06 | -$27,000.04 | N/A | -66.67% | Miss | N/A | 1 | N/A | Dec 20, 2019 |
| Jun 30, 2019 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 28, 2019 |
| Mar 31, 2019 | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$23.91, after -$194.46 the year before. It was -$45,005.66 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$23.91 | N/A |
| Dec 31, 2024 | -$194.46 | N/A |
| Dec 31, 2023 | -$92,225.57 | N/A |
| Dec 31, 2022 | -$225,004.13 | N/A |
| Dec 31, 2021 | -$396,003.56 | N/A |
| Dec 31, 2020 | -$513,000.72 | N/A |
| Dec 31, 2019 | -$45,005.66 | N/A |
Frequently Asked Questions About CNSP
When is CNS Pharmaceuticals's next earnings date?
CNS Pharmaceuticals's next earnings report is expected for Mar 29, 2027.
Did CNSP beat earnings estimates last quarter?
No. CNS Pharmaceuticals reported EPS of -$0.38 for the quarter ended Jun 30, 2026, below the -$0.24 estimate by 58.33%.
What EPS do analysts expect from CNSP next quarter?
The consensus EPS estimate for CNS Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.28 from 3 analysts.
How often does CNSP beat earnings estimates?
CNS Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -85.71%.
CNSP pages: Overview, Earnings, Forecast, Financials, Competitors